FDA Drug Recalls

6 recalls, newest first

May 16, 2017 Class II · Moderate risk

Defective Delivery System: Elevated number of units with out of specification results for leak rate

Ongoing Packaging defect GlaxoSmithKline, LLC NDC 0173-0682-20 D-0793-2017

Apr 21, 2017 Class I · High risk

Presence of Particulate Matter: human hair found within an internal sample syringe.

Ongoing Particulate / foreign matter Hospira Inc. NDC 0409-1775-10 D-0862-2017

Mar 22, 2017 Class II · Moderate risk

Defective Delivery System: Elevated number of units with out of specification results for leak rate.

Ongoing Packaging defect GlaxoSmithKline, LLC NDC 0173-0682-20 D-0626-2017

Mar 12, 2017 Class I · High risk

Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

Ongoing Packaging defect Meridian Medical Technologies a Pfizer Company NDC 49502-500-02 D-0691-2017

Mar 12, 2017 Class I · High risk

Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

Ongoing Packaging defect Meridian Medical Technologies a Pfizer Company NDC 49502-500-02 D-0690-2017

Mar 1, 2017 Class II · Moderate risk

Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.

Ongoing Microbial contamination Signature Club A Ltd D-0662-2017

Recalls by year